Details of the Drug

General Information of Drug (ID: DMH3H3A)

Drug Name
GSK2696274
Indication
Disease Entry ICD 11 Status REF
Metachromatic leukodystrophy 5C56.02 Phase 2 [1]
Cross-matching ID
TTD ID
D0P6LE

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)